Part II  iteM 7 Management’s Discussion and analysis of Financial Condition and results of operations for medical devices and lithium for energy storage specialty polymers  and pharmaceutical synthesis. Our Industrial Chemicals segment  manufactures a wide range of inorganic materials, including soda  ash, hydrogen peroxide, specialty peroxygens, zeolites and silicates.  Through December 31, 2010, our Industrial Chemicals segment also  held a niche position in phosphorous chemicals products, however, in  November 2010, we made the decision to exit the phosphate business  via the shutdown of our Huelva facility in Spain. 2010 highlights 2011 outlook results of operations — 2010, 2009 and 2008 overview Our businesses this year have been positively impacted by the increase  in global economic activity resulting in higher volumes. Results for  2010 reflect increases in both consolidated revenues and earnings in all  three of our operating segments driven by solid performance. Our Agricultural Products segment revenues increased 18 percent  driven by sales gains in North America, Latin America, particularly  Brazil, and Asia due to improved market conditions in several key crops  and growth from new and recently introduced products. Revenue also  increased in our Specialty Chemicals segment with revenues up nine  percent compared to the prior year period. Increases in the Specialty  Chemicals segment were led by a robust demand recovery in lithium  primaries and strong commercial performance in BioPolymer. Our  Industrial Chemicals segment revenues increased three percent from  prior year period as volume gains across all businesses were largely  offset by reduced selling prices and lower electricity sales stemming  from the sale of a Spanish cogeneration facility in 2009. In Spain we  operate electricity cogeneration facilities and sell excess electricity into  the Spanish electrical grid. Agricultural Products operating profit increased seven percent compared  to the prior year period reflecting strong sales performance partially  offset by less favorable mix, higher inventory and distribution costs,  increased selling and administrative expenses and higher spending on  growth initiatives. Specialty Chemicals operating profit grew by 16  percent as volume gains in lithium primaries, favorable commercial  performance in BioPolymer and the benefits of productivity initiatives  were partially offset by higher raw material costs. Industrial Chemicals  operating profit increased 37 percent from the prior year period, driven  by the strong demand recovery and lower raw material, particularly  In 2011, we expect a year of solid performance. We expect to have an  increase to our revenues driven by increased volumes in most regions,  particularly Latin America and Asia, in our Agricultural Products  segment and favorable commercial performance in BioPolymer and  higher selling prices and favorable mix in lithium in our Specialty  Chemicals segment. This revenue increase will be slightly offset by  lower revenue in our Industrial Chemicals segment as growth in soda  ash and peroxygens is expected to be fully offset by the absence of  revenue for the exited phosphate business. The following presents a reconciliation of our segment operating profit to net income attributable to FMC stockholders as seen through the eyes  of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before  interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges). We expect an increase in earnings. The increase will be partially driven  by higher sales as discussed above. Additionally, we expect continued  productivity improvements in our Specialty Chemicals segments as well  as the benefit of cost reduction initiatives in our Industrial Chemicals  segment. Our projected earnings increase will be partially offset by  higher spending on growth initiatives and higher raw material costs  particularly in our Agricultural Products segment. We expect cash flow  from our business segments to remain strong. In November 2010, we made the decision to cease operations at our  Huelva, Spain facility and exit the phosphate business in Europe. The  facility was a part of our subsidiary FMC Foret, S.A. (“Foret”), which is  included in our Industrial Chemicals segment. The closure of the facility  was initiated as a consequence of the Spanish judicial ruling which,  effective January 1, 2011, prohibited us from storing phosphogypsum  on a site adjacent to our production facility. The phosphogypsum is a  byproduct of the process of manufacturing phosphoric acid, which is  used in the manufacturing of our phosphate products. Since receipt of  the unfavorable Spanish judicial ruling, we attempted to pursue strategic  alternatives for our Foret phosphorus business. With no reasonable  economic alternatives, the judicial ruling inhibited our ability to cost  effectively produce our phosphate product and therefore rendered it  uneconomical for FMC to continue operations at the facility. The  Huelva decision resulted in the incurrence of significant restructuring  charges in 2010. phosphate rock, and energy costs which more than offset lower selling  prices across the segment. See “Segment Results” section starting on  page 21 for further discussion on the results of our operating segments. In the fourth quarter of 2010, we announced a new corporate strategy,  which we refer to as Vision 2015. Vision 2015 is focused on driving  sales and earnings growth while sustaining a return on invested capital  well above our cost of capital, and has as one of its key objectives,  achieving a total shareholder return in the top quartile of a broad  group of industry peers. Vision 2015 and its five key elements are  explained in more detail in our strategy section of this Form 10-K  included in Item 1. 19 FMC Corporation    2010 Form 10K